nivolumab + chemotherapy

DRUG2 trials

Sponsors

Bristol-Myers Squibb, Fudan University

Conditions

Esophageal Adenocarcinoma (EAC)Esophageal Squamous Cell Carcinoma (ESCC)Gastric AdenocarcinomaGastro-esophageal Junction AdenocarcinomaResectable Stage II-IIIa Squamous NSCLC

Phase 2

Comparison of Serplulimab Versus Nivolumab in Neoadjuvant Therapy for Resectable Stage II-IIIA Squamous NSCLC

RecruitingNCT07398937

Fudan UniversityResectable Stage II-IIIa Squamous NSCLC

Start: 2026-02-05End: 2029-12-31Target: 116Updated: 2026-02-10

Unknown Phase

Observational Study of Patients Treated With Nivolumab and Chemotherapy for Advanced or Metastatic Esophageal, Gastroesophageal or Gastric Cancer in France

Active, not recruitingNCT06504615

Bristol-Myers SquibbEsophageal Adenocarcinoma (EAC), Esophageal Squamous Cell Carcinoma (ESCC), Gastric Adenocarcinoma +1

Start: 2024-12-10End: 2028-08-31Updated: 2026-04-03